Nafeeza Hafeez

Activity of IPI-504, a Novel Heat-Shock Protein 90 Inhibitor, in Patients With Molecularly Defined Non–Small-Cell Lung Cancer

Lecia V. Sequist, Scott Gettinger, Neil Senzer et al. · Journal of Clinical Oncology · 2010 · 331 citations

Medicine, Oncology, Pharmacology +16

Targeting FGFR overcomes EMT-mediated resistance in EGFR mutant non-small cell lung cancer

Sana Raoof, Iain J. Mulford, Heidie Frisco Cabanos et al. · Oncogene · 2019 · 213 citations · Full text

Medicine, Cancer Biology, Oncology +11

Structures, functions and adaptations of the human LINE-1 ORF2 protein

Eric T. Baldwin, Trevor van Eeuwen, David Hoyos et al. · Nature · 2023 · 123 citations · Full text

Life Sciences, Genetics, Molecular Biology +13

Development of KSQ-4279 as a first-in-class USP1 inhibitor for the treatment of BRCA-deficient cancers

Louise Cadzow, J. Brenneman, H. Liu et al. · European Journal of Cancer · 2020 · 25 citations

Medicine, Molecular Genetics, Oncology +8

HSP90 Inhibition Enhances Antimitotic Drug-Induced Mitotic Arrest and Cell Death in Preclinical Models of Non-Small Cell Lung Cancer

Brenda O’Connell, Katie O’Callaghan, Bonnie Tillotson et al. · PLoS ONE · 2014 · 19 citations · Full text

Medicine, Oncology, Pharmacology +17